• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺病毒介导的 SOCS3 基因转移抑制人非小细胞肺癌细胞的生长并增强其放射敏感性。

Adenovirus-mediated SOCS3 gene transfer inhibits the growth and enhances the radiosensitivity of human non-small cell lung cancer cells.

机构信息

Division of Pulmonary and Critical Care Medicine, Department of Respiratory Care, Chang Gung Memorial Hospital, Chiayi, Taipei, Taiwan, ROC.

出版信息

Oncol Rep. 2010 Dec;24(6):1605-12. doi: 10.3892/or_00001024.

DOI:10.3892/or_00001024
PMID:21042758
Abstract

The Janus kinase-signal transducers and activators of transcription (JAK-STAT) pathway is one of the most important components of cytokine signaling cascades. JAK-STAT signaling pathway modulates various fundamental biological processes and cancer pathogenesis. JAK-STAT is controlled by negative regulators that include suppressors of cytokine signaling (SOCS) proteins. Failure of feedback suppression by SOCS proteins may result in activated JAK-STAT signaling. Methylation-mediated silencing of SOCS3 has been reported in non-small lung cancer (NSCLC) and other human cancers. In this study, we restored SOCS3 expression using adenovirus-mediated gene transfer in NSCLC cells. Infection with a SOCS3-expressing vector inhibited the growth of lung cancer cells, with or without SOCS3 expression, at 2-3 days after infection. The growth inhibition of lung cancer cells was associated with suppressing entry into the S-phase. Restoration of SOCS3 expression induced apoptosis of NSCLC cells that did not express SOCS3. In addition, overexpression of SOCS3 by adenoviral transfer enhanced the radiosensitivity of treated NSCLC cells. In conclusion, our findings may provide insights into the development of applications of SOCS3 gene therapy for lung cancer and, possibly, other human cancers.

摘要

Janus 激酶-信号转导子和转录激活子(JAK-STAT)通路是细胞因子信号级联反应最重要的组成部分之一。JAK-STAT 信号通路调节各种基本的生物过程和癌症的发病机制。JAK-STAT 受到负调节因子的控制,包括细胞因子信号抑制物(SOCS)蛋白。SOCS 蛋白的反馈抑制失败可能导致 JAK-STAT 信号的激活。SOCS3 的甲基化介导的沉默已在非小细胞肺癌(NSCLC)和其他人类癌症中报道。在这项研究中,我们使用腺病毒介导的基因转移在 NSCLC 细胞中恢复 SOCS3 的表达。在感染后 2-3 天,感染 SOCS3 表达载体的肺癌细胞的生长被抑制,无论是否表达 SOCS3。肺癌细胞生长的抑制与抑制进入 S 期有关。SOCS3 表达的恢复诱导不表达 SOCS3 的 NSCLC 细胞凋亡。此外,通过腺病毒转染过表达 SOCS3 增强了治疗的 NSCLC 细胞的放射敏感性。总之,我们的研究结果可能为 SOCS3 基因治疗在肺癌和可能其他人类癌症中的应用提供新的见解。

相似文献

1
Adenovirus-mediated SOCS3 gene transfer inhibits the growth and enhances the radiosensitivity of human non-small cell lung cancer cells.腺病毒介导的 SOCS3 基因转移抑制人非小细胞肺癌细胞的生长并增强其放射敏感性。
Oncol Rep. 2010 Dec;24(6):1605-12. doi: 10.3892/or_00001024.
2
Molecular mechanism underlying the antiproliferative effect of suppressor of cytokine signaling-1 in non-small-cell lung cancer cells.抑制细胞因子信号转导-1 在非小细胞肺癌细胞中抗增殖作用的分子机制。
Cancer Sci. 2013 Nov;104(11):1483-91. doi: 10.1111/cas.12266. Epub 2013 Sep 19.
3
MiR-410 affects the proliferation and apoptosis of lung cancer A549 cells through regulation of SOCS3/JAK-STAT signaling pathway.miR-410 通过调控 SOCS3/JAK-STAT 信号通路影响肺癌 A549 细胞的增殖和凋亡。
Eur Rev Med Pharmacol Sci. 2018 Sep;22(18):5987-5993. doi: 10.26355/eurrev_201809_15933.
4
Activity of the suppressor of cytokine signaling-3 promoter in human non-small-cell lung cancer.细胞因子信号传导抑制因子3启动子在人非小细胞肺癌中的活性
Clin Lung Cancer. 2004 May;5(6):366-70. doi: 10.3816/CLC.2004.n.015.
5
Transfer of suppressor of cytokine signaling 3 by an oncolytic adenovirus induces potential antitumor activities in hepatocellular carcinoma.溶瘤腺病毒介导的细胞因子信号转导抑制因子3转移在肝癌中诱导潜在的抗肿瘤活性。
Hepatology. 2008 Jan;47(1):105-12. doi: 10.1002/hep.21951.
6
SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer.细胞因子信号转导抑制因子3(SOCS-3)常因高甲基化而沉默,并抑制人肺癌细胞的生长。
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14133-8. doi: 10.1073/pnas.2232790100. Epub 2003 Nov 14.
7
[Expression of SOCS3 and Pyk2 and their correlation in non-small cell lung cancer].[细胞因子信号转导抑制因子3和脯氨酸酪氨酸激酶2在非小细胞肺癌中的表达及其相关性]
Zhonghua Bing Li Xue Za Zhi. 2012 Oct;41(10):657-61. doi: 10.3760/cma.j.issn.0529-5807.2012.10.003.
8
SOCS3 expression is inversely correlated with Pyk2 in non-small cell lung cancer and exogenous SOCS3 inhibits proliferation and invasion of A549 cells.SOCS3 在非小细胞肺癌中的表达与 Pyk2 呈负相关,外源性 SOCS3 抑制 A549 细胞的增殖和侵袭。
Pathology. 2012 Aug;44(5):434-40. doi: 10.1097/PAT.0b013e328354ffdf.
9
Suppressors of cytokine signaling abrogate diabetic nephropathy.细胞因子信号抑制剂可阻断糖尿病肾病。
J Am Soc Nephrol. 2010 May;21(5):763-72. doi: 10.1681/ASN.2009060625. Epub 2010 Feb 25.
10
Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms.组蛋白去乙酰化酶抑制剂丁酸钠通过抑制 HDAC8 介导的 SOCS1 和 SOCS3 的上调来抑制骨髓增殖性肿瘤中的 JAK2/STAT 信号通路。
Exp Hematol. 2013 Mar;41(3):261-70.e4. doi: 10.1016/j.exphem.2012.10.012. Epub 2012 Oct 27.

引用本文的文献

1
PEGylated SOCS3 Mimetics Encapsulated into PLGA-NPs as Selective Inhibitors of JAK/STAT Pathway in TNBC Cells.聚乙二醇化 SOCS3 模拟物包封于 PLGA-NPs 中,作为 TNBC 细胞中 JAK/STAT 通路的选择性抑制剂。
Int J Nanomedicine. 2024 Jul 18;19:7237-7251. doi: 10.2147/IJN.S441205. eCollection 2024.
2
Crosstalk between CXCL12/CXCR4/ACKR3 and the STAT3 Pathway.CXCL12/CXCR4/ACKR3 与 STAT3 通路的串扰。
Cells. 2024 Jun 13;13(12):1027. doi: 10.3390/cells13121027.
3
Molecular mechanisms underlying methotrexate-induced intestinal injury and protective strategies.
甲氨蝶呤诱导的肠道损伤的分子机制及保护策略。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Nov;397(11):8165-8188. doi: 10.1007/s00210-024-03164-x. Epub 2024 Jun 1.
4
Galantamine mitigates testicular injury and disturbed spermatogenesis in adjuvant arthritic rats via modulating apoptosis, inflammatory signals, and IL-6/JAK/STAT3/SOCS3 signaling.加兰他敏通过调节细胞凋亡、炎症信号和 IL-6/JAK/STAT3/SOCS3 信号通路减轻佐剂性关节炎大鼠的睾丸损伤和精子发生障碍。
Inflammopharmacology. 2024 Feb;32(1):405-418. doi: 10.1007/s10787-023-01268-z. Epub 2023 Jul 10.
5
SOCS3 protein expression predicts the responses of advanced non-small cell lung cancer patients to platinum-based chemotherapy.SOCS3蛋白表达可预测晚期非小细胞肺癌患者对铂类化疗的反应。
Ann Transl Med. 2023 Jan 31;11(2):94. doi: 10.21037/atm-22-6065.
6
The use of adenoviral vectors in gene therapy and vaccine approaches.腺病毒载体在基因治疗和疫苗方法中的应用。
Genet Mol Biol. 2022 Oct 7;45(3 Suppl 1):e20220079. doi: 10.1590/1678-4685-GMB-2022-0079. eCollection 2022.
7
Structure-Activity Relationship Investigations of Novel Constrained Chimeric Peptidomimetics of SOCS3 Protein Targeting JAK2.靶向JAK2的SOCS3蛋白新型受限嵌合肽模拟物的构效关系研究
Pharmaceuticals (Basel). 2022 Apr 9;15(4):458. doi: 10.3390/ph15040458.
8
SOCS1 counteracts ROS-mediated survival signals and promotes apoptosis by modulating cell cycle to increase radiosensitivity of colorectal cancer cells.SOCS1 通过调节细胞周期来抵抗 ROS 介导的存活信号并促进细胞凋亡,从而增加结直肠癌细胞的放射敏感性。
BMB Rep. 2022 Apr;55(4):198-203. doi: 10.5483/BMBRep.2022.55.4.191.
9
Chimeric Peptidomimetics of SOCS 3 Able to Interact with JAK2 as Anti-inflammatory Compounds.能够与JAK2相互作用的SOCS 3嵌合肽模拟物作为抗炎化合物。
ACS Med Chem Lett. 2020 Mar 19;11(5):615-623. doi: 10.1021/acsmedchemlett.9b00664. eCollection 2020 May 14.
10
Dissociating STAT4 and STAT5 Signaling Inhibitory Functions of SOCS3: Effects on CD8 T Cell Responses.解析SOCS3对STAT4和STAT5信号传导的抑制功能:对CD8 T细胞反应的影响。
Immunohorizons. 2019 Nov 20;3(11):547-558. doi: 10.4049/immunohorizons.1800075.